These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23525798)

  • 1. Gene variants of unknown clinical significance in Lynch syndrome. An introduction for clinicians.
    Sijmons RH; Greenblatt MS; Genuardi M
    Fam Cancer; 2013 Jun; 12(2):181-7. PubMed ID: 23525798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.
    Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M
    Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic screens to identify pathogenic gene variants in the common cancer predisposition Lynch syndrome.
    Drost M; Lützen A; van Hees S; Ferreira D; Calléja F; Zonneveld JB; Nielsen FC; Rasmussen LJ; de Wind N
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9403-8. PubMed ID: 23690608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleotide-directed mutagenesis screen to identify pathogenic Lynch syndrome-associated MSH2 DNA mismatch repair gene variants.
    Houlleberghs H; Dekker M; Lantermans H; Kleinendorst R; Dubbink HJ; Hofstra RM; Verhoef S; Te Riele H
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4128-33. PubMed ID: 26951660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair Variants.
    Patel SA; Longacre TA; Ladabaum U; Lebensohn A; Lin AY; Haraldsdottir S
    Oncologist; 2018 Dec; 23(12):1395-1400. PubMed ID: 30072391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene.
    Drost M; Koppejan H; de Wind N
    Hum Mutat; 2013 Nov; 34(11):1477-80. PubMed ID: 24027009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-step site-directed mutagenesis screen identifies pathogenic
    Houlleberghs H; Dekker M; Lusseveld J; Pieters W; van Ravesteyn T; Verhoef S; Hofstra RMW; Te Riele H
    J Med Genet; 2020 May; 57(5):308-315. PubMed ID: 31784484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next-generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families.
    Talseth-Palmer BA; Bauer DC; Sjursen W; Evans TJ; McPhillips M; Proietto A; Otton G; Spigelman AD; Scott RJ
    Cancer Med; 2016 May; 5(5):929-41. PubMed ID: 26811195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Pathogenicity of Noncoding Mismatch Repair Gene Promoter Variants in Lynch Syndrome.
    Liu Q; Thompson BA; Ward RL; Hesson LB; Sloane MA
    Hum Mutat; 2016 May; 37(5):417-26. PubMed ID: 26888055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A database to support the interpretation of human mismatch repair gene variants.
    Ou J; Niessen RC; Vonk J; Westers H; Hofstra RM; Sijmons RH
    Hum Mutat; 2008 Nov; 29(11):1337-41. PubMed ID: 18951442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
    Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
    J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
    Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N;
    Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genetic variants for clinical management of familial colorectal tumors.
    Dominguez-Valentin M; Nakken S; Tubeuf H; Vodak D; Ekstrøm PO; Nissen AM; Morak M; Holinski-Feder E; Martins A; Møller P; Hovig E
    BMC Med Genet; 2018 Feb; 19(1):26. PubMed ID: 29458332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants.
    Borràs E; Pineda M; Cadiñanos J; Del Valle J; Brieger A; Hinrichsen I; Cabanillas R; Navarro M; Brunet J; Sanjuan X; Musulen E; van der Klift H; Lázaro C; Plotz G; Blanco I; Capellá G
    J Med Genet; 2013 Aug; 50(8):552-63. PubMed ID: 23709753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome.
    Wielders E; Delzenne-Goette E; Dekker R; van der Valk M; Te Riele H
    Fam Cancer; 2017 Apr; 16(2):221-229. PubMed ID: 27873144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial colorectal cancer: eleven years of data from a registry program in Switzerland.
    Kovac M; Laczko E; Haider R; Jiricny J; Mueller H; Heinimann K; Marra G
    Fam Cancer; 2011 Sep; 10(3):605-16. PubMed ID: 21671081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new strategy to screen MMR genes in Lynch Syndrome: HA-CAE, MLPA and RT-PCR.
    Perez-Cabornero L; Velasco E; Infante M; Sanz D; Lastra E; Hernández L; Miner C; Duran M
    Eur J Cancer; 2009 May; 45(8):1485-93. PubMed ID: 19250818
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Borras E; Chang K; Pande M; Cuddy A; Bosch JL; Bannon SA; Mork ME; Rodriguez-Bigas MA; Taggart MW; Lynch PM; You YN; Vilar E
    Cancer Prev Res (Phila); 2017 Oct; 10(10):580-587. PubMed ID: 28765196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.